Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

Vivek Subbiah; Ulrik Lassen; Elena Élez; Antoine Italiano; Giuseppe Curigliano; Milind Javle; Filippo De Braud; Gerald W Prager; Richard Greil; Alexander Stein; Angelica Fasolo; Jan H M Schellens; Patrick Y Wen; Kert Viele; Aislyn D Boran; Eduard Gasal; Paul Burgess; Palanichamy Ilankumaran; Zev A Wainberg

doi:10.1016/S1470-2045(20)30321-1

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

Vivek Subbiah, Ulrik Lassen, Elena Élez, Antoine Italiano, Giuseppe Curigliano, Milind Javle, Filippo De Braud, Gerald W Prager, Richard Greil, Alexander Stein, Angelica Fasolo, Jan H M Schellens, Patrick Y Wen, Kert Viele, Aislyn D Boran, Eduard Gasal, Paul Burgess, Palanichamy Ilankumaran, Zev A Wainberg

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

352 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	The Lancet Oncology
Vol/bind	21
Udgave nummer	9
Sider (fra-til)	1234-1243
Antal sider	10
ISSN	1470-2045
DOI	https://doi.org/10.1016/S1470-2045(20)30321-1
Status	Udgivet - 1 sep. 2020

Adgang til dokumentet

10.1016/S1470-2045(20)30321-1

Citationsformater

Subbiah, V., Lassen, U., Élez, E., Italiano, A., Curigliano, G., Javle, M., De Braud, F., Prager, G. W., Greil, R., Stein, A., Fasolo, A., Schellens, J. H. M., Wen, P. Y., Viele, K., Boran, A. D., Gasal, E., Burgess, P., Ilankumaran, P., & Wainberg, Z. A. (2020). Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial. The Lancet Oncology, 21(9), 1234-1243. https://doi.org/10.1016/S1470-2045(20)30321-1

Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial. / Subbiah, Vivek; Lassen, Ulrik; Élez, Elena; Italiano, Antoine; Curigliano, Giuseppe; Javle, Milind; De Braud, Filippo; Prager, Gerald W; Greil, Richard; Stein, Alexander; Fasolo, Angelica; Schellens, Jan H M; Wen, Patrick Y; Viele, Kert; Boran, Aislyn D; Gasal, Eduard; Burgess, Paul; Ilankumaran, Palanichamy; Wainberg, Zev A.

I: The Lancet Oncology, Bind 21, Nr. 9, 01.09.2020, s. 1234-1243.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Subbiah, V, Lassen, U, Élez, E, Italiano, A, Curigliano, G, Javle, M, De Braud, F, Prager, GW, Greil, R, Stein, A, Fasolo, A, Schellens, JHM, Wen, PY, Viele, K, Boran, AD, Gasal, E, Burgess, P, Ilankumaran, P & Wainberg, ZA 2020, 'Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial', The Lancet Oncology, bind 21, nr. 9, s. 1234-1243. https://doi.org/10.1016/S1470-2045(20)30321-1

Subbiah, Vivek ; Lassen, Ulrik ; Élez, Elena ; Italiano, Antoine ; Curigliano, Giuseppe ; Javle, Milind ; De Braud, Filippo ; Prager, Gerald W ; Greil, Richard ; Stein, Alexander ; Fasolo, Angelica ; Schellens, Jan H M ; Wen, Patrick Y ; Viele, Kert ; Boran, Aislyn D ; Gasal, Eduard ; Burgess, Paul ; Ilankumaran, Palanichamy ; Wainberg, Zev A. / Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial. I: The Lancet Oncology. 2020 ; Bind 21, Nr. 9. s. 1234-1243.

@article{6d0a10f48c044a2fa2e851ae24628185,

title = "Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial",

author = "Vivek Subbiah and Ulrik Lassen and Elena {\'E}lez and Antoine Italiano and Giuseppe Curigliano and Milind Javle and {De Braud}, Filippo and Prager, {Gerald W} and Richard Greil and Alexander Stein and Angelica Fasolo and Schellens, {Jan H M} and Wen, {Patrick Y} and Kert Viele and Boran, {Aislyn D} and Eduard Gasal and Paul Burgess and Palanichamy Ilankumaran and Wainberg, {Zev A}",

year = "2020",

month = sep,

day = "1",

doi = "10.1016/S1470-2045(20)30321-1",

language = "English",

volume = "21",

pages = "1234--1243",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "TheLancet Publishing Group",

number = "9",

}

TY - JOUR

T1 - Dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial

AU - Subbiah, Vivek

AU - Lassen, Ulrik

AU - Élez, Elena

AU - Italiano, Antoine

AU - Curigliano, Giuseppe

AU - Javle, Milind

AU - De Braud, Filippo

AU - Prager, Gerald W

AU - Greil, Richard

AU - Stein, Alexander

AU - Fasolo, Angelica

AU - Schellens, Jan H M

AU - Wen, Patrick Y

AU - Viele, Kert

AU - Boran, Aislyn D

AU - Gasal, Eduard

AU - Burgess, Paul

AU - Ilankumaran, Palanichamy

AU - Wainberg, Zev A

PY - 2020/9/1

Y1 - 2020/9/1

U2 - 10.1016/S1470-2045(20)30321-1

DO - 10.1016/S1470-2045(20)30321-1

M3 - Journal article

VL - 21

SP - 1234

EP - 1243

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 9

ER -